TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis
Zhou Jiang(The University of Texas MD Anderson Cancer Center), Mien‐Chie Hung(The University of Texas MD Anderson Cancer Center)
Cited by 311
Related Papers
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
|Nature Communications|2016|1.1k
STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
|Nature Communications|2018|427
IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
|Journal of Clinical Investigation|2019|380
PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response
|Journal of Clinical Investigation|2015|155
APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis
|Journal of Clinical Investigation|2011|132